Cargando…
Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
Frontotemporal dementia is a clinically, genetically and pathologically heterogeneous neurodegenerative disorder, enclosing a wide range of different pathological entities, associated with the accumulation of proteins such as tau and TPD-43. Characterized by a high hereditability, mutations in three...
Autores principales: | Giunta, Marcello, Solje, Eino, Gardoni, Fabrizio, Borroni, Barbara, Benussi, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005747/ https://www.ncbi.nlm.nih.gov/pubmed/33790662 http://dx.doi.org/10.2147/JEP.S262352 |
Ejemplares similares
-
Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches
por: Huber, Nadine, et al.
Publicado: (2021) -
Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries
por: Logroscino, Giancarlo, et al.
Publicado: (2023) -
Recent advances in understanding frontotemporal degeneration
por: Borroni, Barbara, et al.
Publicado: (2019) -
Genetics of frontotemporal lobar degeneration
por: Aswathy, P. M., et al.
Publicado: (2010) -
Modifiable potential risk factors in familial and sporadic frontotemporal dementia
por: Soppela, Helmi, et al.
Publicado: (2022)